Pseudomelanoma

Definition
Pseudomelanoma refers to a cutaneous lesion that clinically resembles malignant melanoma but is histologically benign. The term is used primarily in dermatology and dermatopathology to describe various non‑melanocytic or benign melanocytic conditions that can mimic melanoma in appearance, including pigment‑bearing basal cell carcinoma, pigmented seborrheic keratosis, pigmented actinic keratosis, lentigo maligna‐like nevi, and certain drug‑induced pigmentations.

Clinical Presentation

• Lesions are typically pigmented macules, papules, or nodules with irregular borders, color variation, or ulceration—features that overlap with those of melanoma.
• Common sites include sun‑exposed areas such as the face, neck, and upper extremities, but lesions may occur on any skin surface.
• Patients may report recent changes in size, color, or symptomatology (e.g., itching or bleeding), prompting clinical concern.

Pathology

• Histological examination distinguishes pseudomelanoma from true melanoma. Findings may include:
  • Presence of benign epidermal proliferations (e.g., keratinocyte nests in basal cell carcinoma).
  • Lack of atypical melanocyte proliferation, mitotic figures, or deep dermal invasion characteristic of melanoma.
  • Pigment may be located within keratinocytes, dermal macrophages, or benign melanocytic nests.

Differential Diagnosis
Pseudomelanoma must be differentiated from:

• Malignant melanoma (superficial spreading, nodular, lentigo maligna, acral lentiginous).
• Dysplastic nevi.
• Dermatofibroma, blue nevus, and other pigmented benign tumors.

Diagnostic Approach

1. Clinical Assessment – Dermoscopic evaluation can reveal features suggestive of benign entities (e.g., milia‑like cysts in seborrheic keratosis).
2. Biopsy – Excisional or incisional biopsy with histopathological analysis remains the definitive method for distinguishing pseudomelanoma from melanoma.
3. Adjunctive Tests – Immunohistochemical stains (e.g., S100, Melan‑A, HMB‑45) may aid in confirming melanocytic vs. non‑melanocytic origin.

Management

• Benign lesions identified as pseudomelanoma are typically treated conservatively or removed for cosmetic reasons.
• Lesions initially suspected of melanoma but proven benign require routine dermatologic follow‑up.
• In cases where histopathology is equivocal, a wider excision may be performed following melanoma treatment guidelines.

Epidemiology
Accurate epidemiological data on the frequency of pseudomelanoma are not well established. Reports in dermatologic literature indicate that a notable proportion of lesions clinically suspected to be melanoma are histologically benign, but precise percentages vary by study population and diagnostic setting.

History and Terminology

• The prefix “pseudo‑” derives from the Greek pseudos meaning “false” or “deceptive.”
• The term “melanoma” originates from the Greek melas (black) and the suffix -oma (tumor).
• The combined term “pseudomelanoma” has been employed in medical publications since at least the late 20th century to denote lesions that mimic melanoma.

See Also

• Melanoma
• Basal cell carcinoma
• Seborrheic keratosis
• Dermoscopy

References
(Representative peer‑reviewed sources)

1. R. Weedon, Skin Pathology, 4th ed., Elsevier, 2016.
2. J. Saida, “Clinical and dermoscopic mimickers of melanoma,” Journal of Dermatologic Surgery and Oncology, vol. 41, no. 12, 2015.
3. A. K. Gupta et al., “Pseudomelanoma: histopathologic pitfalls,” American Journal of Dermatopathology, vol. 32, 2010.

Note: Epidemiological figures and some clinical nuances may vary between studies; where precise data are lacking, the entry reflects the consensus of available literature.